Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Axitinib Looks Good in Head-to-Head Renal Cancer Trial - MedPage Today |
 |
 |
|
MedPage Today In what was described as the first phase III head-to-head comparison of targeted agents in advanced renal cell carcinoma, patients getting axitinib had a median progression-free survival of 6.7 months, according to Brian Rini, MD, of the Cleveland |
